Butodesnitazene

Pharmaceutical compound From Wikipedia, the free encyclopedia

Butodesnitazene is a benzimidazole derivative with opioid effects, which has been sold as a designer drug. It was identified by drug checking services in New Zealand in 2025, having been sold on the black market misrepresented as heroin. Its pharmacological properties have not been studied, although based on the known structure-activity relationships of the benzimidazole opioids, it is expected to have comparatively low potency.[1]

FormulaC24H33N3O
Molar mass379.548 g·mol−1
3D model (JSmol)
Quick facts Identifiers, Chemical and physical data ...
Butodesnitazene
Identifiers
  • 2-[(4-Butoxyphenyl)methyl]-1-(2-diethylaminoethyl)benzimidazole
Chemical and physical data
FormulaC24H33N3O
Molar mass379.548 g·mol−1
3D model (JSmol)
  • CCN(CC)CCn1c(nc2ccccc12)Cc1ccc(OCCCC)cc1
  • InChI=InChI=1S/C24H33N3O/c1-4-7-18-28-21-14-12-20(13-15-21)19-24-25-22-10-8-9-11-23(22)27(24)17-16-26(5-2)6-3/h8-15H,4-7,16-19H2,1-3H3
  • Key:NOCZAWHIDDFBFO-UHFFFAOYSA-N
Close

See also

References

Related Articles

Wikiwand AI